BWCA
ADMS
Brenner West Capital Advisors’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-1,011,431
| Closed | -$20.2M | – | 19 |
|
2018
Q3 | $20.2M | Buy |
1,011,431
+223,708
| +28% | +$4.48M | 2.52% | 18 |
|
2018
Q2 | $20.3M | Sell |
787,723
-159,283
| -17% | -$4.11M | 2.28% | 19 |
|
2018
Q1 | $22.6M | Sell |
947,006
-323,117
| -25% | -$7.72M | 3.09% | 14 |
|
2017
Q4 | $43M | Sell |
1,270,123
-431,354
| -25% | -$14.6M | 5.64% | 8 |
|
2017
Q3 | $36M | Buy |
1,701,477
+281,321
| +20% | +$5.96M | 4.3% | 12 |
|
2017
Q2 | $24.8M | Buy |
1,420,156
+228,874
| +19% | +$4M | 2.89% | 13 |
|
2017
Q1 | $20.8M | Sell |
1,191,282
-30,181
| -2% | -$528K | 2.1% | 13 |
|
2016
Q4 | $20.6M | Buy |
1,221,463
+52,188
| +4% | +$882K | 2.28% | 13 |
|
2016
Q3 | $19.2M | Buy |
1,169,275
+152,275
| +15% | +$2.5M | 1.72% | 14 |
|
2016
Q2 | $15.4M | Buy |
1,017,000
+473,762
| +87% | +$7.17M | 1.34% | 15 |
|
2016
Q1 | $7.86M | Buy |
+543,238
| New | +$7.86M | 0.62% | 14 |
|